Hepatic miR-149-5p upregulation fosters steatosis, inflammation and fibrosis development in mice and in human liver organoids

This publication has 59 references indexed in Scilit:

• En masse organoid phenotyping informs metabolic-associated genetic susceptibility to NASH
  Cell, 2022
• Circulating Fibroblast Growth Factor-21 and Risk of Metachronous Colorectal Adenoma
  Journal of Gastrointestinal Cancer, 2020
• MiR-149 attenuates endoplasmic reticulum stress-induced inflammation and apoptosis in nonalcoholic fatty liver disease by negatively targeting ATF6 pathway
  Immunology Letters, 2020
• miR-149* Suppresses Liver Cancer Progression by Down-Regulating Tumor Necrosis Factor Receptor 1–Associated Death Domain Protein Expression
  The American Journal of Pathology, 2020
• Bta‐miR‐149‐5p inhibits proliferation and differentiation of bovine adipocytes through targeting CRTCs at both transcriptional and posttranscriptional levels
  Journal of Cellular Physiology, 2020
• Generation of multi-cellular human liver organoids from pluripotent stem cells
  2020
• Extracellular miRNAs: From Biomarkers to Mediators of Physiology and Disease
  Cell Metabolism, 2019
• Modeling Steatohepatitis in Humans with Pluripotent Stem Cell-Derived Organoids
  Cell Metabolism, 2019
• Mouse models of nonalcoholic steatohepatitis in preclinical drug development
  Drug Discovery Today, 2017
• Phase I study of MRX34, a liposomal miR-34a mimic, administered twice weekly in patients with advanced solid tumors
  Investigational New Drugs, 2016